Funcaps Trial: 5 Years Prison Sought for Dutch Fake Pill Operators in Belgium

The Belgian Public Prosecutor's Office has demanded five years imprisonment for two Dutch nationals behind the illegal online pharmacy Funcaps, marking a significant escalation in the international crackdown on illegal online drug sales that have been linked to at least 58 deaths across Europe. This development comes as authorities in both Belgium and the Netherlands continue to investigate the devastating impact of the website's operations, which sold designer drugs and fake medications to vulnerable customers.

What is the Funcaps Case?

The Funcaps case involves two Dutch entrepreneurs, Jord van W. (31) and Stefan P. (30), who operated an online platform selling prescription medications, designer drugs, and fake pills without medical oversight. The website, which generated an estimated €42 million in revenue over five years, primarily targeted individuals seeking treatment for anxiety, depression, and sleep disorders rather than recreational drug users. The operation began during the COVID-19 pandemic and expanded across European borders, exploiting legal grey areas in both Dutch and Belgian drug legislation.

Belgian Prosecution Demands Stiffer Penalties

In a recent appeal hearing, Belgian prosecutors dramatically increased their sentencing demands from the original 120 hours of community service and €80,000 fine to five years imprisonment. The prosecution argued that the defendants' activities had a "disastrous influence" on users and specifically requested the court consider the 2021 death of a 44-year-old man who died from an overdose of a designer drug purchased through Funcaps.

"If we had known all this, we would never have done it," stated defendant Jord van W. during proceedings, claiming lack of criminal intent. However, prosecutors countered that the defendants showed systematic disregard for customer safety, with evidence revealing disturbing indifference to the mounting death toll.

WhatsApp Messages Reveal Chilling Indifference

Court documents revealed WhatsApp exchanges between the operators that showed minimal concern for customer fatalities. Messages included phrases like "another dead one" followed by combinations of sad and laughing emojis, suggesting the deaths were treated as collateral damage in their lucrative business. This evidence has become central to both the Belgian and Dutch prosecutions, demonstrating what authorities describe as a callous disregard for human life.

Parallel Dutch Investigation Uncovers Wider Tragedy

While the Belgian case focuses on cross-border drug trafficking, Dutch authorities are investigating a much broader tragedy. The Dutch Public Prosecution Service has identified 58 deaths potentially linked to Funcaps purchases, with nine additional cases under active investigation as of February 2026. The youngest victim was just 17 years old, and many customers were psychologically vulnerable individuals seeking relief from mental health conditions.

The Dutch case reveals a disturbing pattern: in 12 instances, victims received Funcaps deliveries within two weeks of their deaths. The website operated with minimal safeguards, selling highly addictive substances like synthetic benzodiazepines and designer drugs without proper dosage information or medical supervision.

Legal Context: Changing Drug Legislation

The Funcaps case emerges against the backdrop of significant legislative changes in the Netherlands. On July 1, 2025, the Dutch government implemented a comprehensive ban on entire groups of designer drugs, closing legal loopholes that allowed manufacturers to make minor chemical modifications to evade existing laws. This new legislation, which adds List 1A to the Opium Act, specifically targets synthetic cannabinoids, fentanyl derivatives, and phenethylamines including cathinones like 3-MMC.

This legal evolution reflects growing international concern about the online pharmaceutical black market, where unregulated substances pose significant public health risks. The Funcaps operators exploited pre-2025 regulatory gaps, selling substances labeled as "research chemicals" or "not fit for human consumption" while knowing customers were consuming them as medications.

Impact and Implications

The Funcaps tragedy has sparked urgent discussions about online drug regulation, consumer protection, and international law enforcement cooperation. With victims spanning multiple European countries, the case highlights the borderless nature of digital drug markets and the challenges facing national regulatory systems.

Health experts warn that similar operations continue to proliferate online, targeting vulnerable populations with promises of quick solutions to mental health challenges. The case has prompted calls for:

• Enhanced international cooperation between drug enforcement agencies
• Stricter monitoring of online pharmaceutical sales
• Improved public awareness campaigns about the dangers of unregulated medications
• Better support systems for individuals struggling with mental health issues

FAQ: Frequently Asked Questions

What is Funcaps?

Funcaps was an illegal online pharmacy operated by two Dutch nationals that sold prescription medications, designer drugs, and fake pills without medical oversight between approximately 2020-2025.

How many deaths are linked to Funcaps?

Dutch authorities are investigating 58 deaths potentially linked to Funcaps purchases, with nine additional cases under investigation as of February 2026. Belgian authorities are investigating at least one confirmed overdose death.

What charges do the operators face?

In Belgium, prosecutors seek five years imprisonment for illegal drug trafficking. In the Netherlands, they face charges including illegal pharmaceutical operations and potentially causing deaths, with possible sentences up to 30 years.

When is the next court hearing?

The next preliminary hearing in the Dutch case is scheduled for April 20, 2026, at the Zwolle District Court. The Belgian appeal continues with sentencing expected later in 2026.

How much money did Funcaps generate?

Investigators estimate Funcaps generated approximately €42 million in revenue over five years of operation, selling to customers across Europe.

Sources

NL Times: Court Hears Pill Dealers Knew Customers Dying

Dutch News: Fake Medicine Webshop Linked to Deaths

Holland Times: Designer Drugs Ban from July 1, 2025

Euro Security: Netherlands Designer Drugs Under Control